Upstart Life Sciences Capital Ups Commitments To $7.1M
Salt Lake City-based Upstart Life Sciences Capital, a venture firm focused on Unversity life science spinouts, has reached $7.18M in commitments to its $28.5M fund, according to a regulatory filing by the firm Thursday. The fund's General Partners are Steve Borst, Dennis Farrar, and Theodore Stanley. At least one of the firm's LPs include the Utah Fund of Funds, which lists Upstart in its portfolio. Borst and Farrar are previously from Q Therapeutics, and Stanley is Chairman of ZARS.
posted on Thursday, February 25, 2010
Related companies:
Upstart
Related stories:
> Beaker Unveils Online Life Sciences Community
> Utah Industry Group: More Than 1,000 Life Sciences Companies In State
> Isonics Shops Life Sciences Division For $850,000
> Utah IT, Life Sciences Organizations Merge
> NetRegulus Partners With QAD
Techrockies.com Home